Skip to content

Adis in touch

A blog from Adis, a leading global provider of drug information.

Search for:

Recent Posts

Planning and strategizing in the face of evolving regulatory guidelines: Report from the DIA Pharmacovigilance and Risk Management Strategies Conference (PVRMS19)
Researchers investigate how vial sizes can be optimized to reduce pharmaceutical wastage
Pharmacovigilance in the Middle East: Adis PV attends the regional ISoP meeting
The World Drug Safety Congress in Amsterdam addresses key challenges
Avatrombopag (Doptelet®): First Global Approval – Reducing the bleeding risks of invasive procedures in patients with Chronic Liver Disease

Recent Comments

	Dr Paul Tappenden as… on Call for Papers: Themed Issue…
	Dupilumab (Dupixent®… on Dupilumab (Dupixent®): First G…
	Durvalumab (IMFENZI®… on Durvalumab (IMFINZI®): Follow…
	Dupilumab (Dupixent®… on Dupilumab (Dupixent®): First G…
	Baricitinib (Olumian… on Baricitinib (Olumiant™): First…

Archives

Categories

Adis (83)
Adis Journals (91)
Adis Pharmacovigilance (24)
AdisInsight (92)
Uncategorized (2)

September 20, 2016 1440 × 599

cropped-drug-evaluation-istock_000015211851large.jpg

Leave a Reply Cancel reply

Powered by WordPress.com.